Vir Biotechnology loses 5% following Q4 2022 earnings misses Posted on February 24, 2023 By Charlielikes Stock Market
Curative Biotechnology refiles for NYSE uplisting, $8M offering Posted on November 8, 2022 By Charlielikes Stock Market
Vir Biotechnology falls 15% on Q2 revenue miss impacted by ~$400M for potential write-offs Posted on August 10, 2022 By Charlielikes Stock Market